Diebold Nixdorf (DBD) Research & Development (2009 - 2026)

Diebold Nixdorf (DBD) has reported Research & Development for 18 consecutive years, with $20.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 8.48% year-over-year to $20.5 million; the trailing twelve-month figure through Jun 2026 stood at $84.3 million (down 8.77% YoY), and the FY2025 full-year result was $86.7 million, down 7.37% from the prior year.
• Research & Development fell to $20.5 million in Q2 2026 per DBD's latest filing, from $22.1 million in the prior quarter.
• Across five years, Research & Development topped out at $33.1 million in Q2 2022 and bottomed at $12.0 million in Q3 2023.
• Historically, Research & Development has averaged $24.0 million across 5 years, with a median of $23.4 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Research & Development slumped 55.06% in 2023, then surged 95.0% in 2024.
• Over 5 years, Research & Development stood at $28.6 million in 2022, then sank by 58.04% to $12.0 million in 2023, then jumped by 99.17% to $23.9 million in 2024, then dropped by 10.46% to $21.4 million in 2025, then declined by 4.21% to $20.5 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $20.5 million, $22.1 million, and $21.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.